Electroconvulsive therapy (ECT) uses an electric current to treat depression and some other mental illnesses.
Shock treatment; Shock therapy; ECT; Depression - ECT; Bipolar - ECT
During ECT, the electric current triggers a seizure in the brain. Doctors believe that the seizure activity may help the brain "rewire" itself, which helps relieve symptoms. ECT is generally safe and effective.
ECT is most often done in a hospital while you are asleep and pain free (general anesthesia):
ECT is a highly effective treatment for depression, most commonly severe depression. It can be very helpful for treating depression in people who:
Less often, ECT is used for conditions such as mania, catatonia, and psychosis that do not improve enough with other treatments.
ECT has received bad press, in part because of its potential for causing memory problems. Since ECT was introduced in the 1930s, the dose of electricity used in the procedure has been decreased significantly. Also, it may be given with the electrode placed on only one side of the skull (unilateral ECT). These changes have greatly reduced the side effects of this procedure, including memory loss.
However, ECT can still cause some side effects, including:
Some medical conditions put people at greater risk for side effects from ECT. Discuss your medical conditions and any concerns with your health care provider when deciding whether ECT is right for you.
Because general anesthesia is used for this procedure, you will be asked not to eat or drink before ECT.
Ask your provider whether you should take any daily medicines in the morning before ECT.
After a successful course of ECT, you will receive medicines or less frequent ECT to reduce the risk of another episode of depression.
Some people report mild confusion and headache after ECT. These symptoms should only last for a short while.
Perugi G, Medda P, Barbuti M, Novi M, Tripodi B. The role of electroconvulsive therapy in the treatment of severe bipolar mixed state. Psychiatr Clin North Am. 2020;43(1):187-197. PMID: 32008684 pubmed.ncbi.nlm.nih.gov/32008684/.
US Preventive Services Task Force, Barry MJ, Nicholson WK, et al. Screening for depression and suicide risk in adults: US Preventive Services Task Force Recommendation Statement. JAMA. 2023;329(23):2057-2067. PMID: 37338872 pubmed.ncbi.nlm.nih.gov/37338872/.